We may get something like that in a few years but enormous marketing to doctors, and doctors prescribe this at the moment.
-
-
So, they'll get away with charging $600 for ~$2 worth of medicine to many millions at least for one year. Enormous profits.
1 reply 2 retweets 3 likes -
When very similar generic arises, and doctors finally pressured, they will again become Aleve to naproxen sodium. Billions richer.
1 reply 2 retweets 3 likes -
Drug is same but alternative is used slightly differently; this is issue if you might not be the one doing the injecting.
2 replies 0 retweets 6 likes -
Also, for EpiPen the delivery mechanism is important; it's usable by far more people than a syringe
1 reply 1 retweet 4 likes -
Exactly. As someone w a food allergy, I carry the expensive epipen bc I might not be the user in emergency.
4 replies 0 retweets 4 likes
Essentially a marketing blast turned into a monopoly turned into a hostage situation—for however long.
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.